Chemical Compounds for Fighting Bacterial and Yeast Infections

A 1977 patent for a specific class of amino-phosphonous acid chemicals designed to act as antibiotics against bacteria and yeast.

What it covers

The patent describes a group of chemical compounds known as alpha-amino-phosphonous acids. These molecules are structured to interfere with the biological processes of pathogenic bacteria and yeast. By administering these compounds, either orally or through injection, the patent claims a method for treating microbial infections in mammals. The chemical structure relies on a specific arrangement where an amino group and a phosphonous acid group are attached to the same carbon atom, with various side chains (R and R1) attached to modify the molecule's properties.

What it doesn't cover

• —Does not cover compounds where both R and R1 are hydrogen atoms.
• —Does not cover non-amino-phosphonous acid structures.
• —Does not cover the treatment of viral or parasitic infections.
• —Does not cover naturally occurring amino acids that lack the phosphonous acid group.

The clever bit

The innovation lies in the use of the phosphonous acid group as a mimic for the carboxylic acid group found in natural amino acids, allowing the molecule to potentially 'trick' bacterial enzymes into binding with it instead of their normal substrates.

Why it matters

This patent represents a period in pharmaceutical history where researchers were actively exploring synthetic analogs of natural amino acids to disrupt bacterial metabolism. It highlights the development of phosphorus-containing compounds as potential therapeutic agents, a field that has seen ongoing interest in medicinal chemistry for creating enzyme inhibitors.

Real-world examples

• 1.Experimental antibacterial pharmaceutical formulations
• 2.Synthetic amino acid analogs used in biochemical research